Atara Biotherapeutics, Inc. (ATRA)
6.69
+0.19
(+2.92%)
USD |
NASDAQ |
Nov 18, 16:00
6.69
0.00 (0.00%)
After-Hours: 20:00
Atara Biotherapeutics Profit Margin (Quarterly) : -182.1% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -182.1% |
| June 30, 2026 | -767.3% |
| March 31, 2026 | -803.3% |
| December 31, 2025 | -213.5% |
| September 30, 2025 | -124.6% |
| June 30, 2025 | 13.58% |
| March 31, 2025 | 38.73% |
| December 31, 2024 | -38.75% |
| September 30, 2024 | -54.51% |
| June 30, 2024 | -66.51% |
| March 31, 2024 | -116.1% |
| December 31, 2023 | -1.42K% |
| Date | Value |
|---|---|
| September 30, 2023 | -3.26K% |
| June 30, 2023 | -7.43K% |
| March 31, 2023 | -6.10K% |
| December 31, 2022 | -33.74K% |
| September 30, 2022 | -1.89K% |
| June 30, 2022 | 35.80% |
| March 31, 2022 | -1.20K% |
| December 31, 2021 | -1.24K% |
| September 30, 2021 | -1.58K% |
| June 30, 2021 | -2.17K% |
| March 31, 2021 | -2.21K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 15.64% |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | -1.02% |
| Savara, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -1.13K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -65.42% |
| Return on Invested Capital | -94.57% |
| Gross Profit Margin (Quarterly) | 78.35% |
| Operating Margin (Quarterly) | -242.6% |
| Return on Net Operating Assets | -172.5% |